Luwad, Nora Ina S.
HRN: 15-83-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2025
10/25/2025
IV
4.5gm
Q6
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes